Clinical Trial Update: Clinical Pharmacology Study of MP-424 [Phase 1]

View source ↗

Summary

Phase 1 clinical pharmacology study of MP-424 in chronic hepatitis C has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• MP-424

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED